SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

Share Price is delayed by 15 minutes
Get Live Data
77.00    0.00 (0.00%)
Bid:
77.00
Ask:
78.00
Spread: 1.00 (1.299%)
Market Cap: £187.07m
AXS Live PriceLast checked at - London Stock Exchange

Intraday Accsys Tech Share Chart

Trading Update

21 Apr 2026 07:00

RNS Number : 2022B
Accsys Technologies PLC
21 April 2026
 

AIM: AXS

Euronext Amsterdam: AXS

 

21 April 2026

 

Accsys Technologies PLC

("Accsys", the "Group" or the "Company")

 

Trading Update

 

Record Accoya sales volumes with significant strategic progress

 

Accsys, the world's leading supplier of premium, high performance and sustainable wood building materials, today provides an update on its performance for the year ended 31 March 2026 ("FY26"). All numbers in this announcement are unaudited.

 

Accsys is pleased to announce a strong performance for FY26 and expects full-year results to be in line with market consensus¹, reflecting continued significant progress in delivering on Phase 1 of its FOCUS strategy.

 

Full year performance: 

FY26  

Unaudited 

FY25 

Actual 

Change

Like-for-like

change² 

Revenue 

Group

€153m 

€137m

 +12% 

+20%

Aggregated (Group plus Joint Venture)³ 

€183m 

€147m 

+24%

 

Sales Volumes m³ 

Group 

60,384m3

57,104m3

+6%

+13%

Joint Venture (JV)

16,853m3

6,760m3

+149%

 +60% 

Total (Group plus JV) 

77,237m3

63,864m3

+21%

 

 

· Record total global sales volumes of 77,237m3 demonstrate continued strong demand for Accoya amidst challenging macroeconomic conditions:

Group sales volumes up 13% on a like-for-like basis with robust growth in all markets: 60% North America, 12% UK&I, 23% Rest of Europe and 9% Rest of World

9% growth in Accoya for Tricoya

 

· Group revenues increased by 20% on a like-for-like basis driven by solid trading performance across all regions, continued pricing discipline and favourable sales mix reflecting robust demand for Accoya Color, supported by the H1 production capacity increase at Barry, UK

 

· The Company expects FY26 adjusted EBITDA to be in line with market consensus

 

· Excellent performance in North America:

Significant sales volume growth of 60% in North America following the first full financial year of trading for Accoya USA, demonstrating the sizeable market opportunity. This growth captures the brand strength, pricing power and innovative technology of our products and effective commercial and operational execution

Management has successfully mitigated the impact of tariffs on imported lumber into the USA, introduced in October 2025, and is continuing to monitor the situation

 

· Continued focus on capital allocation towards deleveraging with reduction in leverage ratio and net debt to €41.4m at 31 March 2026 (€42.6m, 31 March 2025)

Dr Jelena Arsic van Os commented:

"I am proud of Accsys' impressive performance in FY26, reflecting disciplined execution of our FOCUS strategy, with record Accoya volumes driving strong revenue growth, continued market share gains and significantly improved profitability. Our differentiated offering is resonating with customers, and the progress of our Accoya USA joint venture reinforces the strength of our strategic positioning in North America.

While remaining mindful of current geopolitical events, we are delivering against our priorities, strengthening the business, enhancing resilience, and building a scalable platform for sustainable long-term growth."

The Group's financial results for the year ended 31 March 2026 will be announced on the 16 June 2026.

Notes:

1) Accsys considers market consensus FY26 Adjusted EBITDA to be €21.0 million as at 31 March 2026.

2) The comparative period, FY25, included 3,802m³ of Group sales to North America. Since the start-up of Accoya USA in September 2024 all North American sales are served by the JV. The like-for-like change in sales volumes and revenues excludes the effect of these sales from the FY25 Group comparators whilst including them within the FY25 JV sales volumes comparator.

3) Accsys has a 60% shareholding in Accoya USA, a joint venture (JV) with Eastman Chemical Company which commenced operations during H1 FY25. Whilst the JV is equity accounted for financial reporting purposes, the aggregated revenue figure includes 60% of the JV revenue.

4) At constant exchange rates, aggregated revenue growth would be +25%

5)Total Sales Volumes include all Group sales and 100% of sales from the JV

6) Adjusted EBITDA being earnings before interest, tax, depreciation, amortisation and exceptional items of Accsys plus 60% of the JV's EBITDA.

 

 

Ends

Enquiries:

Accsys Investor Relations ir@accsysplc.com

 

Panmure Liberum (London) - Nomad and Broker

Nicholas How (NOMAD), Will King +44 (0) 20 3100 2000

 

ABN Amro (Amsterdam) - Broker

Richard van Etten, Dennis van Helmond +31 (0) 20 344 2000

 

Camarco (UK) accsys@camarco.co.uk

Ginny Pulbrook, Tom Huddart, Tilly Butcher +44 (0)20 3757 4980

Huijskens Sassen Communications (NL)

Clemens Sassen, Tessa Nelissen +31 (0) 20 68 55 955

Notes to editors:

 

Accsys (Accsys Technologies PLC) is disrupting the building materials industry with its high-performance wood products and proprietary technology. Driven by its purpose of "changing wood to change the world", Accsys takes fast-growing, certified sustainable wood and turns it into long lasting, eco-friendly building materials - backed by warranties of up to 50 years. Operating in the rapidly growing global wood construction market, Accsys has an established manufacturing footprint in Europe and North America with active product distribution in more than 25 countries. Accsys is listed on the London Stock Exchange AIM market and on Euronext Amsterdam, under the symbols 'AXS'.

Accsys is a Participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business.

Visit www.accsysplc.com 

 

Accoya® is the global leader for high-performance wood. Created through a proprietary acetylation process developed by Accsys, Accoya delivers superior durability and stability, backed by an industry-leading warranty of up to 50 years. It holds Cradle to Cradle Certified® Gold (Full Scope - V3.1) status for its circular economy benefits. Combining the natural beauty of wood with exceptional performance, Accoya is the preferred choice for windows, doors, cladding, and decking - outperforming hardwoods and manmade materials in durability, stability, and sustainability.

Tricoya® acetylated wood chips redefine panel products, creating next-generation panels that thrive outdoors and in wet environments. Recognised as the biggest leap in wood composites in over 30 years, Tricoya panels combine the strength and versatility of traditional products with unmatched durability and eco-friendliness - backed by a warranty of up to 50 years - expanding design and construction possibilities like never before.

To find out more visit: www.accoya.com

Any references in this announcement to agreements with Accsys shall mean agreements with either Accsys or its subsidiary entities unless otherwise specified. 'Accsys' and 'Accsys Technologies' are trading names of Titan Wood Limited ("TWL"), a wholly-owned subsidiary of Accsys Technologies PLC. Accoya®, Tricoya® and the Trimarque Device are registered trademarks owned by TWL, and may not be used or reproduced without written permission from TWL, or in the case of the Tricoya® registered brand trademark, from Tricoya Technologies Limited, a subsidiary of TWL with exclusive rights to exploit the Tricoya® brand.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFLDSTIIFIR
Date   Source Headline
31st Mar 20087:00 amRNSDirector's Interests
28th Mar 20087:01 amRNSDirector's Interests
25th Mar 20087:01 amRNSFull License Agreement
14th Mar 20087:00 amRNSNotifiable Interest
12th Mar 20083:16 pmRNSHolding(s) in Company
11th Mar 20087:00 amRNSNorwegian Agency Agreement
12th Feb 20087:00 amRNSQuarterly Performance Update
31st Jan 20087:01 amRNSTotal Voting Rights
10th Jan 200812:05 pmRNSAdditional Listing
11th Dec 20077:01 amRNSUAE Rights & Expand Capacity
21st Nov 20077:01 amRNSInterim Results
20th Nov 20077:15 amRNSChina License Agreement
20th Nov 20077:01 amRNSNew Business Relationship
15th Oct 20077:00 amRNSLicense Option Agreement
11th Oct 20074:19 pmRNSDirector/PDMR Shareholding
11th Oct 20072:00 pmRNSDirector/PDMR Shareholding
11th Oct 20077:00 amRNSAppointment of new CEO
28th Sep 20077:00 amRNSTotal Voting Rights
26th Sep 20077:01 amRNSDirector's Interests
18th Sep 20077:02 amRNSEuronext Amsterdam Admission
13th Sep 20072:53 pmRNSSUPPLEMENTARY PROSPECTUS
5th Sep 20077:01 amRNSAdditional Listing
4th Sep 20077:02 amRNSProposed Listing
3rd Sep 20077:01 amRNSChina Option Agreement
20th Aug 20077:00 amRNSLISTING ON EURONEXT AMSTERDAM
17th Aug 20077:00 amRNSNew Appointment
16th Aug 20077:00 amRNSHolding(s) in Company
2nd Aug 20076:05 pmRNSTotal Voting Rights
27th Jul 200710:00 amRNSAdditional Listing
28th Jun 20077:01 amRNSPRELIMINARY RESULTS
25th Jun 20077:02 amRNSAgreement
21st Jun 20074:59 pmRNSHolding(s) in Company
4th Jun 20077:01 amRNSHolding(s) in Company
31st May 20077:01 amRNSTotal Voting Rights
24th May 20072:07 pmRNSHolding(s) in Company
23rd May 20079:14 amRNSAppointment
21st May 200711:49 amRNSCompletion of Subscription
16th May 20077:01 amRNSDirectors Options
15th May 20073:19 pmRNSEGM Statement
30th Apr 20072:13 pmRNSTotal Voting Rights
24th Apr 20077:01 amRNSDirector/Notifiable Interests
11th Apr 20077:01 amRNSPosting of circular
2nd Apr 20077:00 amRNSDirector/PDMR Shareholding
28th Mar 20072:18 pmBUSCelanese Corporation Announces Strategic Partnership with Accsys Technologies for Innovative Use of Acetyl Products
28th Mar 20077:04 amRNSStrategic Partnership
19th Mar 20077:02 amRNSProduction commences
6th Feb 20077:00 amRNSHolding(s) in Company
10th Jan 20077:01 amRNSNew Contract
15th Dec 20064:09 pmRNSTotal Voting Rights
13th Dec 200612:52 pmRNSInterim Results - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.